Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, July 11, 2009, 11:29PM ET - U.S. Markets Closed. Dow Down 0.45% Nasdaq Up 0.20%
Endo Pharmaceuticals Holdings Inc. (ENDP)On Jul 10: 17.09  Down 0.25 (1.44%)  
MORE ON ENDP
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Fri, Jul 10, 2009
Endo buys rights to bladder cancer drug
AP (Fri 11:46am)
Endo licenses bladder cancer treatment from Bioniche
at bizjournals.com (Fri 11:05am)
UUPDATE 1-Bioniche inks licensing agreement with Endo
at Reuters (Fri 9:52am)
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
PR Newswire (Fri 8:00am)
Fri, Jul 3, 2009
A Rocky Week For Abbott Labs
at Investopedia (Fri, Jul 3)
Wed, Jul 1, 2009
Endo Pharmaceuticals Earnings Call scheduled for Thu, July 30
CCBN (Wed, Jul 1)
[video] The Obama Trade: Healthcare
at CNBC (Wed, Jul 1)
Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
PR Newswire (Wed, Jul 1)
FDA Panel: Down With Percocet & Vicodin. Long Live NyQuil!
at The Wall Street Journal Online (Wed, Jul 1)
U.S. panel recommends painkiller restrictions
at MarketWatch (Wed, Jul 1)
Tue, Jun 30, 2009
UPDATE - US experts urge stronger limits for some pain drugs
at Reuters (Tue, Jun 30)
Fri, Jun 26, 2009
Top-Rated Stocks That Treat Shareholders Right
at Motley Fool (Fri, Jun 26)
Fri, Jun 19, 2009
More Buyouts Seen In Generic Drug Sector
Investor's Business Daily (Fri, Jun 19)
Wed, Jun 17, 2009
TheFortuneFinancial.com Free Market Research on ENDP, ENER, FNSR and ALTU
Marketwire (Wed, Jun 17)
Tue, Jun 16, 2009
Durect Offers Long-Term Upside
Zacks.com (Tue, Jun 16)
Wed, Jun 10, 2009
Endo Plays With Pain
at Forbes.com (Wed, Jun 10)
Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options
PR Newswire (Wed, Jun 10)
Tue, Jun 9, 2009
7 Small Caps to Lead Your Portfolio Out of the Bear Market
at Motley Fool (Tue, Jun 9)
Endo, Penwest, license Opana ER rights to Valeant
AP (Tue, Jun 9)
Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
GlobeNewswire (Tue, Jun 9)
Older Headlines - Download Recent Headlines
View headlines from:
Add ENDP News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage